Literature DB >> 19556371

Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae.

David Landman1, Simona Bratu1, John Quale1.   

Abstract

Isolates of Klebsiella pneumoniae harbouring the carbapenemase KPC may have carbapenem MICs that remain in the susceptible range, and may therefore go unrecognized. To understand the mechanisms contributing to the variability in carbapenem MICs, 20 clinical isolates, all belonging to either of two clonal groups of KPC-possessing K. pneumoniae endemic to New York City, were examined. Expression of genes encoding KPC, the porins OmpK35 and OmpK36, and the efflux pump AcrAB was examined by real-time RT-PCR. Outer-membrane profiles of selected KPC-producing isolates were examined by SDS-PAGE, and proteins were identified by matrix-assisted laser desorption/ionization mass spectrometry. The identification of SHV and TEM beta-lactamases and the genomic sequences of ompK35 and ompK36 were determined by PCR and DNA sequencing, respectively. For one clonal group, carbapenem MICs increased with decreasing expression of ompK36. A second clonal group also had carbapenem MICs that correlated with ompK36 expression. However, all of the isolates in this latter group continued to produce OmpK36, suggesting that porin configuration may affect entry of carbapenems. For isolates that had the greatest expression of ompK36, carbapenem MICs tended to be lower when determined by the broth microdilution technique, and scattered colonies were seen around the Etest zones of inhibition. All of the KPC-producing isolates were highly resistant to ertapenem, regardless of ompK36 expression. In conclusion, isolates of KPC-possessing K. pneumoniae that express ompK36 tend to have lower MICs to carbapenems and therefore may be more difficult to detect by clinical laboratories. Regardless of ompK36 expression, all of the KPC producers were consistently resistant to ertapenem.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19556371      PMCID: PMC2887543          DOI: 10.1099/jmm.0.012575-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  29 in total

1.  Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration.

Authors:  V T Cao; G Arlet; B M Ericsson; A Tammelin; P Courvalin; T Lambert
Journal:  J Antimicrob Chemother       Date:  2000-12       Impact factor: 5.790

2.  Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.

Authors:  Neil Woodford; Philip M Tierno; Katherine Young; Luke Tysall; Marie-France I Palepou; Elaina Ward; Ronald E Painter; Deborah F Suber; Daniel Shungu; Lynn L Silver; Kenneth Inglima; John Kornblum; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

Review 3.  Multidrug efflux pumps of gram-negative bacteria.

Authors:  H Nikaido
Journal:  J Bacteriol       Date:  1996-10       Impact factor: 3.490

4.  Porin expression in clinical isolates of Klebsiella pneumoniae.

Authors:  Santiago Hernández-Allés; Sebastián Albertí; Dolores Álvarez; Antonio Doménech-Sánchez; Luis Martínez-Martínez; José Gil; Juan M Tomás; Vicente J Benedí
Journal:  Microbiology       Date:  1999-03       Impact factor: 2.777

5.  Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.

Authors:  P A Bradford; C Urban; N Mariano; S J Projan; J J Rahal; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

6.  High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe.

Authors:  Frank M Kaczmarek; Fadia Dib-Hajj; Wenchi Shang; Thomas D Gootz
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

7.  Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory.

Authors:  Neil Woodford; John W T Dallow; Robert L R Hill; Marie-France I Palepou; Rachel Pike; M Elaina Ward; Marina Warner; David M Livermore
Journal:  Int J Antimicrob Agents       Date:  2007-02-12       Impact factor: 5.283

8.  Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection.

Authors:  Simona Bratu; Mohamad Mooty; Satyen Nichani; David Landman; Carl Gullans; Barbara Pettinato; Usha Karumudi; Pooja Tolaney; John Quale
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

9.  Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance.

Authors:  Antonio Doménech-Sánchez; Luis Martínez-Martínez; Santiago Hernández-Allés; María del Carmen Conejo; Alvaro Pascual; Juan M Tomás; Sebastián Albertí; Vicente Javier Benedí
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

10.  Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.

Authors:  Jia Chang Cai; Hong Wei Zhou; Rong Zhang; Gong-Xiang Chen
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

View more
  54 in total

1.  Role of ISKpn7 and deletions in blaKPC gene expression.

Authors:  Thierry Naas; Gaelle Cuzon; Ha-Vy Truong; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

Review 2.  Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.

Authors:  Louis B Rice
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

3.  Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae.

Authors:  Spyros Pournaras; Ioulia Kristo; Georgia Vrioni; Alexandros Ikonomidis; Aggeliki Poulou; Dimitra Petropoulou; Athanassios Tsakris
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

4.  Contribution of β-lactamases and porin proteins OmpK35 and OmpK36 to carbapenem resistance in clinical isolates of KPC-2-producing Klebsiella pneumoniae.

Authors:  Ying Zhang; Xiaofei Jiang; Yanyan Wang; Gang Li; Yueru Tian; Hong Liu; Fuqi Ai; Yiming Ma; Bei Wang; Feiyi Ruan; Kumar Rajakumar
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

5.  Activity of Meropenem with a Novel Broader-Spectrum β-Lactamase Inhibitor, WCK 4234, against Gram-Negative Pathogens Endemic to New York City.

Authors:  Alejandro Iregui; Zeb Khan; David Landman; John Quale
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

6.  Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae.

Authors:  Alex Agyekum; Alicia Fajardo-Lubián; Xiaoman Ai; Andrew N Ginn; Zhiyong Zong; Xuejun Guo; John Turnidge; Sally R Partridge; Jonathan R Iredell
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

7.  Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniae.

Authors:  Andrea Endimiani; Kristine M Hujer; Andrea M Hujer; Mark E Pulse; William J Weiss; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

Review 8.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 9.  Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae.

Authors:  Agnese Lupo; Krisztina M Papp-Wallace; Parham Sendi; Robert A Bonomo; Andrea Endimiani
Journal:  Diagn Microbiol Infect Dis       Date:  2013-10-03       Impact factor: 2.803

10.  Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems.

Authors:  Jae H Hong; Cornelius J Clancy; Shaoji Cheng; Ryan K Shields; Liang Chen; Yohei Doi; Yanan Zhao; David S Perlin; Barry N Kreiswirth; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.